190 related articles for article (PubMed ID: 37569690)
21. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
22. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
[TBL] [Abstract][Full Text] [Related]
23. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of NMDA-Mediated Responses by Amyloid-β Peptide 1-40 in Rat Sympathetic Preganglionic Neurons.
Lai CC; Lo H; Lin HG; Lin HH
J Alzheimers Dis; 2019; 67(4):1291-1303. PubMed ID: 30714959
[TBL] [Abstract][Full Text] [Related]
26. Prevention of amyloid-beta oligomer-induced neuronal death by EGTA, estradiol, and endocytosis inhibitor.
Cižas P; Jekabsonė A; Borutaitė V; Morkūnienė R
Medicina (Kaunas); 2011; 47(2):107-12. PubMed ID: 21734444
[TBL] [Abstract][Full Text] [Related]
27. The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.
Tamagno E; Guglielmotto M; Monteleone D; Manassero G; Vasciaveo V; Tabaton M
J Alzheimers Dis; 2018; 62(3):1241-1245. PubMed ID: 29103036
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic and functional analysis of Aβ
Smit T; Ormel PR; Sluijs JA; Hulshof LA; Middeldorp J; de Witte LD; Hol EM; Donega V
Brain Behav Immun; 2022 Feb; 100():219-230. PubMed ID: 34896594
[TBL] [Abstract][Full Text] [Related]
29. Amyloid β peptide oligomers directly activate NMDA receptors.
Texidó L; Martín-Satué M; Alberdi E; Solsona C; Matute C
Cell Calcium; 2011 Mar; 49(3):184-90. PubMed ID: 21349580
[TBL] [Abstract][Full Text] [Related]
30. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.
Floden AM; Li S; Combs CK
J Neurosci; 2005 Mar; 25(10):2566-75. PubMed ID: 15758166
[TBL] [Abstract][Full Text] [Related]
31. Rhynchophylline suppresses soluble Aβ
Yang Y; Ji WG; Zhu ZR; Wu YL; Zhang ZY; Qu SC
Neuropharmacology; 2018 Jun; 135():100-112. PubMed ID: 29510187
[TBL] [Abstract][Full Text] [Related]
32. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.
Alberdi E; Sánchez-Gómez MV; Cavaliere F; Pérez-Samartín A; Zugaza JL; Trullas R; Domercq M; Matute C
Cell Calcium; 2010 Mar; 47(3):264-72. PubMed ID: 20061018
[TBL] [Abstract][Full Text] [Related]
33. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
34. An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.
Adolfsson O; Pihlgren M; Toni N; Varisco Y; Buccarello AL; Antoniello K; Lohmann S; Piorkowska K; Gafner V; Atwal JK; Maloney J; Chen M; Gogineni A; Weimer RM; Mortensen DL; Friesenhahn M; Ho C; Paul R; Pfeifer A; Muhs A; Watts RJ
J Neurosci; 2012 Jul; 32(28):9677-89. PubMed ID: 22787053
[TBL] [Abstract][Full Text] [Related]
35. Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss.
Birnbaum JH; Bali J; Rajendran L; Nitsch RM; Tackenberg C
Cell Death Dis; 2015 Jun; 6(6):e1791. PubMed ID: 26086964
[TBL] [Abstract][Full Text] [Related]
36. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
[TBL] [Abstract][Full Text] [Related]
37. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.
Ng J; Kaur H; Collier T; Chang K; Brooks AES; Allison JR; Brimble MA; Hickey A; Birch NP
J Biol Chem; 2019 May; 294(22):8806-8818. PubMed ID: 30996005
[TBL] [Abstract][Full Text] [Related]
38. 1MeTIQ provides protection against Aβ-induced reduction of surface expression of synaptic proteins and inhibits H₂O₂-induced oxidative stress in primary hippocampal neurons.
Kuszczyk MA; Sadowski MJ; Antkiewicz-Michaluk L; Lazarewicz JW
Neurotox Res; 2014 May; 25(4):348-57. PubMed ID: 24254130
[TBL] [Abstract][Full Text] [Related]
39. Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation.
Yu F; Gong P; Hu Z; Qiu Y; Cui Y; Gao X; Chen H; Li J
J Neuroinflammation; 2015 Jun; 12():122. PubMed ID: 26104799
[TBL] [Abstract][Full Text] [Related]
40. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.
De Felice FG; Velasco PT; Lambert MP; Viola K; Fernandez SJ; Ferreira ST; Klein WL
J Biol Chem; 2007 Apr; 282(15):11590-601. PubMed ID: 17308309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]